ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0438 • ACR Convergence 2020

    Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice

    Jessica Farrell1, Mitchell Miller1, Kelsey Hennig2, Kelley Powers3, Sooyeon Kwon4, Denae Moyer5, Kathryn French5, Angela Citta5 and Jacqueline Cleary1, 1Albany College of Pharmacy and Health Sciences, Albany, NY, 2Albany College of Pharmacy and Health Sciences, New Lebanon, NY, 3The Center for Rheumatology, Delanson, NY, 4Albany Stratton VA Hospital, Loudonville, NY, 5Albany College of Pharmacy and Health Sciences, Albany

    Background/Purpose: With the evolution of DMARDs, the need for opioids in the treatment of rheumatic diseases has decreased. However, rheumatology professionals are often presented with…
  • Abstract Number: 0433 • ACR Convergence 2020

    Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus

    Shivani Garg1, Christie Bartels2, Gaobin Bao3, Cristina Drenkard4 and S. Sam Lim3, 1UW Madison, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI, 3Emory University, Atlanta, GA, 4Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

    Background/Purpose: In the US, cardiovascular disease (CVD) is the leading cause of disparities in life expectancy between black and white populations. We recently reported a…
  • Abstract Number: 0428 • ACR Convergence 2020

    Enrichment of Clinical Trial Recruitment Using Advanced Molecular Imaging in Takayasu’s Arteritis

    Kaitlin Quinn1, Mark Ahlman2, Emily Rose3, Peter Merkel4 and Peter C. Grayson5, 1Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, 2National Institutes of Health, Clinical Center, Radiology and Imaging Sciences, Bethesda, MD, 3Systemic Autoimmunity Branch, Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4University of Pennsylvania, Philadelphia, PA, 5Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD

    Background/Purpose: Definitions of disease activity are not standardized in Takayasu’s arteritis (TAK), which can lead to difficulty in determining whether a patient should be enrolled…
  • Abstract Number: 0442 • ACR Convergence 2020

    Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate

    Maria Antonelli1 and Nora Singer2, 1MHMC/CWRU, Cleveland, OH, 2The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: In the initial months of the SARS CoV2/COVID19 pandemic, broad use of off-label therapy with hydroxychloroquine (HCQ) was prescribed to reduce CoV2-related morbidity and…
  • Abstract Number: 0441 • ACR Convergence 2020

    Use of an Integrated Care Management Program to Uncover and Address Social Determinants of Health for Individuals with Lupus

    Kreager Taber1, Jessica Williams1, Weixing Huang2, Katherine McLaughlin1, Christine Vogeli3, Rebecca Cunningham1, Lisa Wichmann1 and Candace Feldman4, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 3Massachusetts General Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston

    Background/Purpose: The burden of systemic lupus erythematosus (SLE) falls disproportionately on racial/ethnic minorities and individuals of lower socioeconomic status who often receive fragmented, inconsistent care.…
  • Abstract Number: 0447 • ACR Convergence 2020

    Magnetic Resonance Imaging Characteristics in Patients with Spondyloarthritis and Clinical Diagnosis of Heel Enthesitis: Screening Data from a Phase 3 Trial

    Xenofon Baraliakos1, Philipp Sewerin2, Eugenio De Miguel3, Christine Kleinmond4, Ankita Shekhawat5, Claudia Jentzsch6, Annette Wiedon7 and Frank Behrens8, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 2Department of Rheumatology & Hiller Research Unit, University Hospital Düsseldorf, Duesseldorf, Germany, 3Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 4ClinProject GmbH, Eurasburg, Germany, 5Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 6Novartis Pharma GmbH, Nuremberg, Germany, 7Novartis Pharma GmbH, Nurnberg, Germany, 8CIRI/Rheumatology & Fraunhofer TMP, Goethe University, Frankfurt, Germany

    Background/Purpose: Inflammation and pain at entheseal sites are the key clinical signs in patients (pts) with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).1 Magnetic resonance…
  • Abstract Number: 0446 • ACR Convergence 2020

    Novel Ultrasound Image Acquisition Protocol and Scoring System for the Pediatric Ankle

    Patricia Vega-Fernandez1, Deirdre De Ranieri2, Edward Oberle3, Hulya Bukulmez4, Clara Lin5, Susan Shenoi6, Akaluck Thatayatikom7, Leandra Woolnough8, Kathleen Jo Corbin9, Heather Benham10, Emily Brunner11, Michael Henrickson1, Laura Ballenger3, Sara Haro12, Christina Schutt13, Jean-Philippe Proulx-Gauthier14, Ginger Janow15, Mekibib Altaye16, Amy Cassedy1, Johannes Roth17 and Tracy Ting1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Lurie Children's Hospital, Chicago, IL, 3Nationwide Children's Hospital, Columbus, OH, 4MetroHealth Medical Center, Case Western Reserve, Pepper Pike, OH, 5Children's Hospital Colorado, Aurora, CO, 6Seattle Childrens Hospital, seattle, WA, 7Department of Pediatrics, University of Florida, Gainesville, FL, 8University of Florida, Gainesville, FL, 9Yale University School of Medicine, Woodbridge, CT, 10Texas Scottish RIte Hospital, North Richland Hills, TX, 11Geisinger, Bloomsburg, PA, 12UCSF, San Francisco, CA, 13University of Pittsburgh Medical Center, Pittsburgh, PA, 14CHU de Quebec - Universite Laval, Quebec, Canada, 15Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health, Hackensack, NJ, 16Cincinnati Children's Hospital Medical Center, Cincinnati, 17University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: The clinical decision-making process in pediatric arthritis lacks an objective, reliable bedside imaging tool. Although increasingly used for children, there is a need for…
  • Abstract Number: 0452 • ACR Convergence 2020

    Recombinant Zoster Vaccine in Patients with Rheumatic Diseases: A Retrospective Study of 622 Patients

    Tiphaine Lenfant1, Elizabeth Kirchner2, Rula Hajj-ali3, Leonard Calabrese3 and Cassandra Calabrese3, 1Cleveland Clinic Foundation, Rocky River, OH, 2Cleveland Clinic Foundation, Cleveland, 3Cleveland Clinic, Cleveland, OH

    Background/Purpose: The recombinant herpes zoster vaccine (RZV) was FDA-approved in 2017 but patients with rheumatic diseases were excluded from initial pivotal trials because of theoretical…
  • Abstract Number: 0454 • ACR Convergence 2020

    Anticytokine Therapies for Inflammatory Rheumatic Disease (IRD) Are Associated with Reduced Hospitalisation Following Community COVID-19 Infection; Results of the Trinity Rheumatology and Covid-19 Registry – TRACR

    Rachael Flood1, Richard Conway2, David Kane1 and Ronan Mullan1, 1Tallaght University Hospital, Dublin, Ireland, 2St James's Hospital, Dublin, Ireland

    Background/Purpose: Anticytokine biological disease modifying anti-rheumatic drugs (bDMARD), which are widely prescribed  for Inflammatory Rheumatological Diseases (IRD) are currently undergoing clinical trials for the treatment…
  • Abstract Number: 0449 • ACR Convergence 2020

    Cytotoxic T Cells with a Chronic Antigen Exposure Phenotype Drive Immune Checkpoint Inhibitor Sicca

    Blake Warner1, Billel Gasmi2, David Kleiner3, Paola Perez Riveros4, Daniel Barber5, Shunsuke Sakai5 and Alan Baer6, 1National Institute of Dental and Craniofacial Research, Bethesda, 2National Cancer Institute, Bethesda, MD, 3National Cancer Institute, Bethesda, 4National Institute of Dental and Craniofacial Research, Bethesda, MD, 5National Institute of Allergy and Infectious Disease, Bethesda, MD, 6Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Immune checkpoint inhibitors (ICI) have advanced the field of cancer therapeutics. By blocking the negative co-stimulation of T cells, ICI augment the anti-tumor immune…
  • Abstract Number: 0444 • ACR Convergence 2020

    Chronological Order of Decrease of Synovitis, Osteitis and Tenosynovitis in Early Arthritis Patients Receiving First DMARD-treatment

    Xanthe Matthijssen1, Ellis Niemantsverdriet1, Saskia le Cessie1 and Annette van der Helm - van Mil2, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Advanced imaging modalities have shown that not only joints but also bones and tendon sheaths can be inflamed at diagnosis of rheumatoid arthritis. We…
  • Abstract Number: 0457 • ACR Convergence 2020

    Improving Pneumococcal Vaccination Rates in Immunosuppressed Rheumatology Patients

    Julia Harris1, Michael Holland2, Emily Fox2, Amy Ivy3, Maria Ibarra2, Cara Hoffart2, Jordan Jones2, Leslie Favier4 and Ashley Cooper2, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Kansas City, MO, 3Children's Mercy Kansas City, Kansas City, 4Children's Mercy Kansas City, Leawood, KS

    Background/Purpose: The Centers for Disease Control and Prevention recommends pneumococcal vaccination of high-risk patients, including patients on iatrogenic immunosuppression. Many patients seen in the rheumatology…
  • Abstract Number: 0460 • ACR Convergence 2020

    Lymphocyte Clonal Expansion Distinguishes Different Forms of Uveitis

    Michael Paley1, Lynn Hassman1, Philip Ruzycki1, Ekaterina Esaulova1, Grace Paley1, Jennifer Laurent1, Luke Springer1, Lacey Feigl1, Maxim Artyomov1 and Wayne Yokoyama2, 1Washington University, Saint Louis, 2Washington University, St Louis, MO

    Background/Purpose: Anterior uveitis is a form of ocular inflammation associated with rheumatologic disease and can be categorized as granulomatous or non-granulomatous. Whether different ocular manifestations…
  • Abstract Number: 0461 • ACR Convergence 2020

    High-Throughput Single-Cell Analysis Reveals Unique Lung Cellular Subsets in a Murine Model of Rheumatoid Arthritis-Inflammatory Lung Disease

    Rohit Gaurav1, Ted Mikuls1, Geoffrey Thiele1, Amy Nelson1, Meng Niu1, Chittibabu Guda1, James Eudy1, Austin Barry1, Debra Romberger1, Michael Duryee1, Bryant England1 and Jill Poole1, 1University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA)-associated inflammatory lung disease is an extra-articular manifestation of RA associated with increased morbidity and mortality, whose precise molecular mechanisms remain undetermined.…
  • Abstract Number: 0456 • ACR Convergence 2020

    Reduced Risk of Serious Pneumococcal Infection up to 10 Years After Immunization with 7-valent Conjugated Pneumococcal Vaccine in Patients with Inflammatory Arthritis

    Johanna Nagel1, Göran Jönsson2, Jan Åke Nilsson3, Chanchai Manuswin4, Martin Englund5, Tore Saxne1, Pierre Geborek1 and Meliha Kapetanovic1, 1Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden, Lund, Sweden, 2Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Infection Medicine, Lund, Sweden, Lund, Sweden, 3Rheumatology, Department of Clinical Sciences, Malmö, Lund University. Department of Rheumatology, Skåne University Hospital, Malmö and Lund, Sweden, Malmö, Sweden, 4Centre of Registers South, Skåne University Hospital, Lund, Sweden, Lund, Sweden, 5Lund University, Lund, Sweden

    Background/Purpose: The aim was to examine the rates of putative pneumococcal infections up to 10 years before and after administration of heptavalent conjugated pneumococcal vaccine…
  • « Previous Page
  • 1
  • …
  • 655
  • 656
  • 657
  • 658
  • 659
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology